Company / PP&E per Share
Acadia Pharmaceuticals PP&E per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.05
FY2025
5-year range
$0.03 / $0.05
FY2021-FY2025
Trend
+76.0%
vs FY2024
Sector context
#121 of 191
Health Care
What the data says
At $0.05, Acadia Pharmaceuticals's pp&e per share ranks #121 of 191 in the Health Care sector. PP&E per Share returned to growth in FY2025 after 4 years of decline, reaching $0.05.
Based on SEC 10-K filings.
0.05 in FY2025 with a 5-year CAGR of -5.2%.
Improved from $0.03 to $0.05 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- +6.4%
- 5-Year CAGR
- -5.2%
- 10-Year CAGR
- -
Sector benchmark
#121 of 191 in Health CareTop 63% of 191This company $0.05 Sector average $18.90
▼
-99.8% below sector average
Key checks
Key Insights
- In FY2025, pp&e per share increased 76.0% year-over-year.
- Ranks #121 out of 191 companies in the Health Care sector.
- Peak pp&e per share was recorded in FY2020.
- Lowest pp&e per share in the period was in FY2017.
Company context
Key Data Points
- Strong profit margin: 24.9%
- Low earnings quality (accrual-heavy earnings)
- Strong return on equity: 28.5%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.05 | +76.0% |
| FY2024 | $0.03 | -10.0% |
| FY2023 | $0.03 | -23.9% |
| FY2022 | $0.04 | -25.8% |
| FY2021 | $0.05 | -14.6% |
| FY2020 | $0.06 | +166.9% |
| FY2019 | $0.02 | -16.9% |
| FY2018 | $0.03 | +21.3% |
| FY2017 | $0.02 | -27.4% |
| FY2016 | $0.03 | +37.3% |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026